Major Clinical Trial on Hypertension indicates the importance of intensive treatment
It has been a while since there has been a landmark clinical trial on hypertension and I would like to bring the following important paper and accompanying Commentaries to your attention:
'A Randomized Trial of Intensive versus Standard Blood-Pressure Control. The SPRINT Research Group. New Eng J Med November 9, 2015DOI: 10.1056/NEJMoa1511939'
This study investigated the most appropriate targets for systolic blood pressure to reduce cardiovascular morbidity and mortality among persons without diabetes. The trial, funded by the NIH, showed that intensive treatment to achieve a target of systolic blood pressure of 120 mmHg rather than 140 mmHg reduced cardiovascular morbidity and death by almost 30%. This study clearly shows that more intensive blood pressure control can save lives.
Please read the paper and commentaries and look out for a report on the SPRINT study by Profs Lindholm and Poulter in the December ISH of the ISH Newsletter - Hypertension News.
Your President, Rhian
Latest Tweets: Follow us
The ISH is positively committed to opposing discrimination against people on the grounds of gender, race, colour, nationality, religion, marital status, sexual orientation, class, age, disability, having dependants, HIV status or perceived lifestyle.